CROs/Service Providers

ClinPharm Consulting changes name to Kinetigen

Monday, February 4, 2013 11:26 AM

ClinPharm Consulting, a specialty pharmaceutical consulting firm with global reach, has changed its name to Kinetigen. All management, scientific and operational components of Kinetigen remain the same as under ClinPharm, including the consulting firm’s focus on clinical pharmacology and pharmacokinetics.

More... »

Solvias acquires Confarma

Monday, February 4, 2013 10:55 AM

Pharmaceutical service provider Solvias  has acquired Confarma, a global provider of scientific services, and its subsidiary Confarma France. The acquisition is a key component of the forward-looking growth strategy of Solvias and Confarma.

More... »

Icon to acquire clinical trial services division of Cross Country Healthcare

Monday, February 4, 2013 09:14 AM

Icon, a global provider of outsourced development services, has agreed to acquire the clinical trial services division of Cross Country Healthcare, a healthcare staffing and outsourcing services company, for a cash consideration of $52 million, plus an earn-out of up to $3.75 million related to certain performance-based milestones. The transaction is expected to close within the next 30 days. 

More... »

JLL Partners to acquire BioClinica and CoreLab Partners

Wednesday, January 30, 2013 11:36 AM

BioClinica, a global provider of clinical trial management solutions, has entered into a definitive agreement to be acquired by a holding company controlled by JLL Partners, a private equity firm.

More... »

PharmaNet/i3 renamed inVentiv Health Clinical

Wednesday, January 30, 2013 11:07 AM

inVentiv Health,  a global provider of clinical, commercial and consulting services, announced that its existing CRO, PharmaNet/i3, will be renamed inVentiv Health Clinical. This renaming reflects the closer alignment between the clinical segment and inVentiv's commercial and consulting services.

More... »

Variance makes growth investment in Veristat

Friday, January 25, 2013 09:56 AM

Holliston, Mass.-based CRO Veristat said Variance Development Partners, a private investment group focused on contributing growth capital to small to mid-sized firms serving developing pharmaceutical and medical device companies, has made a growth equity investment in the company.

More... »

Foundation Medicine expands Series B financing to $56M

Wednesday, January 23, 2013 03:07 PM

Foundation Medicine, a Cambridge Mass.-based molecular information company, has expanded its Series B financing, raising an additional $13.5 million and bringing the total raised in the round to $56 million. The new investors include Bill Gates, Evan Jones and Yuri Milner.

More... »

Verum.de to provide clinical research services for oncology center in Romania

Wednesday, January 23, 2013 02:38 PM

Verum.de, a Germany-based full-clinical service CRO, has entered into an agreement with the Center for Oncologic Diagnosis and Treatment (Oncocard) in Romania to be its preferred provider of clinical trial services.

More... »

Invacare completes sale of medical supplies business to AssuraMed

Wednesday, January 23, 2013 10:56 AM

Invacare, an Elyria, Ohio-based manufacturer and distributor of home and long-term care medical products, has completed the sale of its Invacare Supply Group (ISG) medical supplies business to AssuraMed, a medical supply distributor based in Twinsburg, Ohio, for a purchase price of approximately $150.8 million in cash.

More... »

Almac completes Knowledge Transfer Partnership with Queens University

Wednesday, January 23, 2013 10:28 AM

Global service provider Almac has successfully completed the Knowledge Transfer Partnership (KTP) with Queens University Belfast, to develop, improve and embed bioprocesses in order to facilitate the delivery of novel products for its biocatalysis business. 

More... »